Clinical trial
Phase I Clinical Study of E7389
NCT00326950 · Eisai Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00326950 |
|---|---|
| Title | Phase I Clinical Study of E7389 |
| Official title | Phase I Clinical Study of E7389 in Patients With Solid Tumors |
| Lead sponsor | Eisai Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | E7389 |
| Enrollment | 15 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 17, 2006 |
| Last update posted | Mar 8, 2012 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: